Skip to main content
Long-term follow-up confirms sustained efficacy of pembrolizumab in heavily pretreated PMBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Long-term follow-up confirms sustained efficacy of pembrolizumab in heavily pretreated PMBCL
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Primary Mediastinal B-Cell Lymphoma
0
1
Monoclonal Antibody
0
0.95
Prognosis
0
0.75
Refractory
0
0.44
B-Cell Lymphoma
0
1
Lymphoma
0
0.29
Specialty
Lead
score
Hematology-Oncology
1
1
Pulmonary Medicine
0
1
Edit Tags